|
|
|
Insider
Information: |
Gagnon Robert E. |
Relationship: |
Director |
City: |
Weston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
359,945 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,926,619 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
359,945 |
|
|
Total
Value |
$3,926,619 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
18
|
Stock
price went up :
|
0
|
10
|
Stock
price went down : |
0
|
8
|
|
|
|
Gain/Loss Ratio : |
0.0
|
1.3
|
Percentage
Gain/Loss : |
0.0%
|
120.6%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biogen Idec Inc |
BIIB |
Vice President, Finance |
2012-02-29 |
3,999 |
|
0 |
Premium* |
|
Clean Harbors Inc |
CLH |
EVP CFO and Treasurer |
2012-09-11 |
7,386 |
2012-09-11 |
0 |
Premium* |
|
Harvard Bioscience Inc |
HBIO |
Chief Financial Officer |
2018-08-29 |
321,169 |
2014-06-16 |
0 |
Premium* |
|
Verastem, Inc. |
VSTM |
Director |
2024-03-19 |
27,391 |
2018-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
100 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CLH |
Clean Harbors Inc |
EVP CFO and Treasurer |
|
2012-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
7,386 |
7,386 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2014-06-30 |
4 |
A |
$3.87 |
$6,730 |
D/D |
1,739 |
6,739 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2014-12-31 |
4 |
A |
$4.00 |
$7,460 |
D/D |
1,865 |
8,604 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
26,500 |
35,104 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2015-08-03 |
4 |
A |
$0.00 |
$0 |
D/D |
28,117 |
63,221 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2016-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
177,304 |
242,549 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
217,392 |
474,073 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Chief Financial Officer |
|
2018-05-24 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
411,857 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2018-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
51,000 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2019-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
151,000 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2020-03-27 |
4 |
A |
$0.00 |
$0 |
D/D |
62,500 |
213,500 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2020-08-11 |
4 |
A |
$0.00 |
$0 |
D/D |
290,210 |
503,710 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2020-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
67,925 |
571,635 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2021-12-15 |
4 |
A |
$0.00 |
$0 |
D/D |
148,500 |
584,398 |
0 |
- |
|
VSTM |
Verastem, Inc. |
Chief Financial Officer |
|
2022-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
607,880 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2010-12-06 |
4 |
AS |
$66.53 |
$52,957 |
D/D |
(796) |
11,610 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-01-04 |
4 |
AS |
$66.55 |
$339,690 |
D/D |
(5,103) |
10,814 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-02-17 |
4 |
AS |
$67.10 |
$49,115 |
D/D |
(732) |
10,537 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-02-24 |
4 |
AS |
$66.99 |
$70,606 |
D/D |
(1,054) |
11,223 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-03-02 |
4 |
AS |
$69.02 |
$98,164 |
D/D |
(1,402) |
9,486 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-05-04 |
4 |
AS |
$96.03 |
$20,646 |
D/D |
(215) |
8,720 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-05-06 |
4 |
AS |
$96.13 |
$92,960 |
D/D |
(967) |
7,753 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-10-03 |
4 |
AS |
$92.55 |
$72,004 |
D/D |
(778) |
7,635 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-10-05 |
4 |
AS |
$97.66 |
$24,610 |
D/D |
(252) |
7,383 |
0 |
- |
|
BIIB |
Biogen Idec Inc |
Chief Acct Officer VP & Contr |
|
2011-11-09 |
4 |
AS |
$112.04 |
$89,184 |
D/D |
(796) |
6,216 |
0 |
- |
|
100 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|